ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1281

The Brazilian Registry of Juvenile Dermatomyositis: Relationship Between Ultraviolet Radiation and Laboratory Markers of Juvenile Dermatomyositis in a Tropical Country

Beatriz Carneiro1, Adriana Elias2, Claudia Saad-Magalhaes3, Erick Kill2, Sylvia Farhat2, Teresa Robazzi4, Ana Julia Moraes5, Sheila Oliveira6, Luciana Carvalho7, Taciana Fernandes3, Carlos Rabello8, Maria Teresa Terreri9, Silvana Sacchetti10, Simone Appenzeller11, Clovis Silva12, Claudio Len13, Darcisio Antonio14, Iloite Scheibel15, Melissa Fraga16, Marcia Bandeira17, Andre Cavalcante18, Ana Paula Vecchi19, Roberto Marini20, Flavio Sztajnbok21, Nadia Aikawa22, lucia Maria Campos2, Katia Kozu2 and Maria Paula Ribeiro2, 1University of São Paulo, São Paulo, SP, Brazil, 2University of Sao Paulo, São Paulo, SP, 3São Paulo State University, Botucatu, 4University of Bahia, Salvador, 5Para Federal University, Belém do Pará, 6Rio de Janeiro Federal University, Rio de Janeiro, Brazil, 7University of São Paulo (Ribeirao Preto), Ribeirao Preto, 8Albert Sabin Children's Hospital, Fortaleza, 9UNIFESP, São Paulo, SP, Brazil, 10Santa Casa Medical School, São Paulo, SP, Brazil, 11Unicamp, Campinas, SP, Brazil, 12Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil, 13Federal University of Sao Paulo, São Paulo, SP, 14São Paulo State University, Botucatu, SP, Brazil, 15Conceição's Hospital of Porto Alegre, Porto Alegre, 16Universidade Federal de São Paulo, São Paulo, SP, Brazil, 17Pequeno Principe Hospital, Curitiba, 18Pernambuco Federal University, Recife, 19Children's Hospital of Goiania, Goiânia, 20Campinas State University, Campinas, 21UFRJ/UERJ, SAO PAULO, Brazil, 22Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil

Meeting: ACR Convergence 2024

Keywords: Biomarkers, dermatomyositis, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Pediatric Rheumatology – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Ultraviolet (UV) waves are risk factors for juvenile dermatomyositis (JDM), when compared to other types of myositis without skin involvement. Patients with JDM have photosensitive lesions that can result in increased disease activity from varying sun exposure. Rider, L. et al. (2020) demonstrated the relationship between UV exposure and the risk of developing DM in adults, with individual sun exposure being a risk factor for DM. Therefore, the objective of this study is to evaluate the individual sun exposure of Brazilian children and adolescents before the diagnosis of JDM and the relationship with laboratory and functional parameters.

Methods: A national registry was set up, enrolling new onset JDM cases in 18 hospitals during 3-years (2015-2018) in 12 different Brazilian states (Figure 1). Laboratory tests (CK, ALT, AST, aldolase, LDH, PCR, ESR), the number of immunosuppressive medications and functional tests: Childhood Myositis Assessment Scale (CMAS); Disease Activity Score (DAS) and Manual Muscle Testing (MMT) were correlated with UV radiation levels from data of National Aeronautics and Space Administration (NASA) UV waves at the time of JDM symptoms (Figure 2).

Results: Ninety-six (96) children and adolescents with a median age of 10 years were evaluated, and the majority of patients (59.37%) were in areas with a moderate UV radiation, 20.83% in areas of very high UV radiation and 19.79% in high UV radiation areas. No patient included in the study came from areas of predominant low UV radiation throughout the year. In the correlation analysis between UV rates and clinical and laboratory variables, based on the Kruskal-Wallis test, there was statistical relevance between the UV rates and CK levels at the time of onset of JDM symptoms. The median CK in the group with mild UV incidence was 130 IU/ml; in moderate UV group was 590 IU/ml; in high UV group was 186 IU/ml and very high UV group was 6612 IU/ml, with p=0.035. There was also statistical relevance with p= 0.006 in the correlation between UV rates and ALT levels, with the median of the mild UV group of 24.56 IU/ml; moderate UV group of 80 IU/ml; high UV group of 40 IU/ml and very high UV group of 435 IU/ml. There was no statistical relevance in the correlations between UV radiation and AST, DHL, aldolase, CRP and ESR. There was also no statistical relevance in the correlation between UV rays and CMAS, DAS, MMT and the number of immunosuppressive medications in use.

Conclusion: This preliminary analysis of a JDM registry in a tropical country demonstrated an association between CK and ALT levels in regions with greater exposure to UV rays, showing that in regions with higher UV levels there were higher rates of these laboratory markers. These quantitative tools indicate greater disease activity in JDM, therefore in regions with greater UV radiation there were higher levels of CK and ALT at the onset of JDM symptoms. These tests are easy to perform, so they can be good markers of JDM activity in a country with few resources and limited access to other diagnostic tools.

Supporting image 1

Figure 1. Geographic distribution of JDM cases in Brazil

Supporting image 2

Figure 2. Geographic distribution of UV radiation in Brazil


Disclosures: B. Carneiro: None; A. Elias: None; C. Saad-Magalhaes: None; E. Kill: None; S. Farhat: None; T. Robazzi: None; A. Moraes: None; S. Oliveira: None; L. Carvalho: None; T. Fernandes: None; C. Rabello: None; M. Terreri: None; S. Sacchetti: None; S. Appenzeller: None; C. Silva: GlaxoSmithKlein(GSK), 5; C. Len: None; D. Antonio: None; I. Scheibel: None; M. Fraga: None; M. Bandeira: None; A. Cavalcante: None; A. Vecchi: None; R. Marini: None; F. Sztajnbok: None; N. Aikawa: GlaxoSmithKlein(GSK), 5; l. Campos: None; K. Kozu: None; M. Ribeiro: None.

To cite this abstract in AMA style:

Carneiro B, Elias A, Saad-Magalhaes C, Kill E, Farhat S, Robazzi T, Moraes A, Oliveira S, Carvalho L, Fernandes T, Rabello C, Terreri M, Sacchetti S, Appenzeller S, Silva C, Len C, Antonio D, Scheibel I, Fraga M, Bandeira M, Cavalcante A, Vecchi A, Marini R, Sztajnbok F, Aikawa N, Campos l, Kozu K, Ribeiro M. The Brazilian Registry of Juvenile Dermatomyositis: Relationship Between Ultraviolet Radiation and Laboratory Markers of Juvenile Dermatomyositis in a Tropical Country [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-brazilian-registry-of-juvenile-dermatomyositis-relationship-between-ultraviolet-radiation-and-laboratory-markers-of-juvenile-dermatomyositis-in-a-tropical-country/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-brazilian-registry-of-juvenile-dermatomyositis-relationship-between-ultraviolet-radiation-and-laboratory-markers-of-juvenile-dermatomyositis-in-a-tropical-country/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology